A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF

Clinical trial NCT03925194 · RECRUITING

Trial details

NCT number: NCT03925194
Sponsor: Heidelberg University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis, 10011762

Start date: 2022-12-01
Primary completion: 2026-12-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.